Tracking liver tumor medicine on CT during radiation
Part of Cancer, Digestive system clinical trials.
This study checks whether a special “contrast” medicine used in liver cancer can be clearly seen on CT images while you receive radiation. The goal is to better track where the medicine is during treatment, which may improve how radiation is guided.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are (or will be) getting a liver-focused radiation treatment called SABR at a study site
- You received a contrast medicine that shows up on CT scans (for example Lipiodol or DC Bead LUMI)
- That contrast medicine is (or will be) in the camera’s view during the during-treatment cone-beam CT (CBCT) scans
- You can give consent in writing for the study, or your situation fits criteria where consent can be waived
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to plan radiation therapy for lung cancer by using a special imaging technique (functional lung imaging) to see which parts of your lungs work best. The goal is to reduce damage to healthy lung tissue while still targeting the cancer.
This trial is for people with liver cancer (hepatocellular carcinoma) who are about to receive a type of internal radiation therapy called TARE (also known as radioembolization). Researchers want to learn more about how the cancer responds to this treatment using scans and biopsies. You might be a good fit if you have not had any prior treatment for your liver cancer.
This study compares a standard radiation dose plan versus a plan that adjusts the dose based on how the tumor responds to radiation-related measurements. It aims to improve how well stereotactic body radiation therapy (SBRT) treats liver cancer while keeping side effects manageable.
This study tests a special CT scan used during procedures to treat tumors, like blocking blood flow or burning the tumor. It may help doctors see tumors more clearly during the treatment.
This trial studies a targeted liver radiation procedure that uses tiny radioactive beads to treat colon cancer spread mostly in the liver. It may help people whose liver tumors cannot be removed or treated with other common local treatments, but it has several safety and “screening” checks.
This study looks at how the liver changes in size after radiation therapy. It uses CT scans taken before and after treatment to measure these changes, which could help doctors better understand and manage side effects.
Hear when a new Liver Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.